The current management of COVID-19 is mostly limited to general supportive care and
symptomatic treatment. Ivermectin is a broad-spectrum anti-parasitic drug used widely for …

Background The role of ivermectin in the treatment of COVID-19 is still under debate, yet the
drug has been widely used in some parts of the world, as shown by impressive market data …

Background Ivermectin became a popular choice for COVID-19 treatment among clinicians
and the public following encouraging results from pre-print trials and in vitro studies. Early …

Purpose Given the coronavirus disease 2019 (COVID-19) pandemic, there is a global
urgency to discover an effective treatment for patients withthis disease. This study aimed to …

Background To date no effective therapy has been demonstrated for COVID-19. In vitro,
studies indicated that ivermectin (IVM) has antiviral effect. Objectives To assess the …

Ivermectin is an FDA‐approved drug for a parasitic disease that has broad antiviral activity.
This study aims to analyse the efficacy of ivermectin in improving the Covid‐19 outcomes …

Background Ivermectin which was widely considered as a potential treatment for COVID-19,
showed uncertain clinical benefit in many clinical trials. Performing large-scale clinical trials …

Background We systematically assessed benefits and harms of the use of ivermectin (IVM)
in patients with coronavirus disease 2019 (COVID-19). Methods Published and preprint …

Objective Ivermectin has been suggested as a treatment for COVID-19. This randomised
control trial was conducted to test the efficacy of Ivermectin in the treatment of mild and …

Researchers around the world are working at record speed to find the best ways to treat and
prevent coronavirus disease 2019 (COVID‐19). This study aimed to evaluate the efficacy of …